Neuromodulation trials

Neuromodulation and Attention Deficits in MDD

RecruitingNCT07111169Phase: NAStarted 2024-01-01

Summary

Multimodal study (Behavior, TMS, EEG) combining a sham-controlled intermittent theta burst stimulation (iTBS) intervention with an additional-singleton task and EEG to evaluate whether left dorsolater

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
55 Years

Locations

The Clinical Hospital of Chengdu Brain Science Institute, ChChengdu, Sichuan, China

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT07111169